Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole and Misoprostol for Early Pregnancy Loss
NCT06452719Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Aug 2024
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in early pregnancy loss (EPL), sponsored by University of Pennsylvania. Started Aug 2024; status: completed.
02
Drugs
letrozole
03
Conditions
early pregnancy loss (EPL)
Beyond the preview
Go deeper on NCT06452719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06452719.